Topical delivery of liposomally encapsulated gamma-interferon.
The extent of uptake of gamma interferon (gamma-IFN) in various strata of hairless mouse, human and hamster skin upon application of a liposomal formulation and an aqueous solution were determined by in vitro diffusion cell experiments. For each of the animal species studied, 70-80% of the liposomally entrapped IFN was deposited onto or penetrated into the skin as determined 24 h after in vitro application. However, a significant fraction of this total amount (approximately 0.25-0.30) is either adsorbed to or associated with the stratum corneum. The drug content found in the deeper skin strata, where the receptor sites reside, suggests that drug deposition is strongly influenced by the skin species tested. The percent of applied drug found in this strata 24 h after application followed the order: hamster (6.1) much greater than human (0.9) greater than hairless mouse (0.3), although the amounts of drug in the total skin of each species tested were approximately the same. This indicates that the deposition of drug into the living epidermis and/or dermis cannot be predicted by determination of the amount of drug in the total skin. The amounts in the deeper skin strata were also in the order of increasing number of follicles/hair in the skin species, suggesting that the transfollicular route is an important pathway for liposomal topical therapeutics.
du Plessis
J
J
College of Pharmacy, University of Michigan, Ann Arbor 48109.
Egbaria
K
K
Ramachandran
C
C
Weiner
N
N
D000287:Administration, Topical; D000818:Animals; D006224:Cricetinae; D004337:Drug Carriers; D006801:Humans; D007371:Interferon-gamma / Q000008:administration & dosage* / Q000032:analysis; D008081:Liposomes; D051379:Mice; D008812:Mice, Hairless; D012867:Skin / Q000378:metabolism; D012996:Solutions
D004337:Drug Carriers; D008081:Liposomes; D012996:Solutions; D007371:Interferon-gamma